# XCath Robotics

> XCath Robotics is a Houston-based medical robotics company building next-generation endovascular robotic systems and steerable smart guidewires to treat stroke, brain aneurysms and other neurovascular conditions. Its flagship Iris system is the only endovascular robot in development capable of intracranial navigation, and the company is racing toward a clinical telerobot that could let a specialist perform a brain-clot removal on a patient hundreds of miles away.

- **Founded:** 2017
- **Headquarters:** Houston, Texas, United States
- **Founders:** Eduardo Fonseca (CEO), Fred Moll (Chairman of the Board)
- **Team size:** ~54 employees
- **Products:** Iris Endovascular Robotic System, ElectroSteer Deflectable Guidewire System
- **Notable:** First-in-human brain aneurysm procedures using the Iris robotic system (November 2025) - the second time in history a surgical robot was used in an intracranial neurovascular intervention., Only robot in the world to have performed an intracranial neurovascular procedure involving robotic manipulation of three devices., Completed the first telerobotic stroke case (mechanical thrombectomy) - 'Operation Robo Angel' - including a procedure performed on a patient roughly 120 miles from the surgeon.

## Products & services

- **Iris Endovascular Robotic System** — A bedside robotic device that manipulates endovascular tools during local and telerobotic procedures with sub-millimeter precision. Compatible with multiple guidewires, catheters and treatment devices, it uses a dexterous positioning arm and a remote physician unit that reduces radiation exposure and musculoskeletal strain. It is the only endovascular robot in development capable of intracranial navigation, and operates with standard monoplane imaging.
- **ElectroSteer Deflectable Guidewire System** — Described as the world's first electronically-controlled steerable smart guidewire. Built from Nitinol and stainless steel with an electrically-actuated, dual-direction deflectable distal tip and radiopaque markers for X-ray visualization. It can operate standalone via a battery-powered handheld controller or integrate directly with the Iris system.

## Achievements

- First-in-human brain aneurysm procedures using the Iris robotic system (November 2025) - the second time in history a surgical robot was used in an intracranial neurovascular intervention.
- Only robot in the world to have performed an intracranial neurovascular procedure involving robotic manipulation of three devices.
- Completed the first telerobotic stroke case (mechanical thrombectomy) - 'Operation Robo Angel' - including a procedure performed on a patient roughly 120 miles from the surgeon.
- Only endovascular robotic system in development capable of intracranial navigation using standard monoplane imaging.
- Raised $30M Series C, bringing total funding to $92M, co-led by surgical-robotics pioneer Fred Moll.

## Latest updates

- **2026-03** — Secured $30M Series C co-led by Crescent Enterprises and Fred Moll, bringing total funding to $92M, to develop a clinical telerobot capable of mechanical thrombectomy.
- **2025-11** — Iris robotic system used in first-in-human procedures to treat patients with complex brain aneurysms.
- **2025** — Completed the first telerobotic stroke case ('Operation Robo Angel'), treating a patient roughly 120 miles from the operating physician.

## Links

- Website: https://xcath.com
- LinkedIn: https://www.linkedin.com/company/xcath

---

Profile page: https://yespress.io/xcath-robotics
Published by YesPress — https://yespress.io
Last updated: 2026-06-12